Researchers identified a correlation between multisystem immune-related adverse events and improved rates of survival. This new information will be helpful in discussing with patients the spectrum of immune side effects that may occur from immunotherapy and the implications for their future.
Click here for original story, Drugs create balancing act for patients with non-small cell lung cancer
Source: ScienceDaily